Clinical Studies | UVBioTek Phototherapy

            
    Contact : 800-882-4683

Clinical Studies

Narrowband ultraviolet B phototherapy improves the quality of life in patients with psoriasis
OBJECTIVE: To examine whether narrowband ultraviolet B (NBUVB) phototherapy administration to plaque-type psoriatic patients leads to an improvement in patient’s quality of life (QoL)…

Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy
SUMMARY: Psoriasis is a chronic fluctuating dermatosis with demonstrable impact on patients’ quality of life. Our aim was to investigate if narrowband UVB phototherapy administered to psoriatic patients in a standardized manner leads to an improvement in patients’ perceived quality of life…

Clearance is not a realistic expectation of psoriasis treatment
OBJECTIVE: The purpose of this article is to assess whether complete clearance is a realistic expectation given the currently available treatments for psoriasis…

No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study
Phototherapy of skin diseases such as psoriasis is an effective and safe treatment modality. However, increasing the risk of skin cancer by phototherapy is a serious concern…

Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study)
OBJECTIVE: To determine whether ultraviolet B phototherapy at home is equally safe and equally effective as ultraviolet B phototherapy in an outpatient setting for patients with psoriasis…

Psoriasis drug promises big results, but price and side effects temper enthusiasm
Take a shot and make it go away. That’s quite tempting if you have a disease like psoriasis, an often itchy, painful skin problem that can take months to get rid of. But doctors at leading centers are raising concerns that new injectable medicines — a class of drugs called biologics — for the skin disease can bring their own problems, including infections that trigger more skin outbreaks, tuberculosis and rare cases of lymphoma, a type of cancer…

Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel
OBJECTIVE: We attempted to evaluate the efficacy of narrow-band UVB phototherapy in combination with topical tazarotene…

Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 (PPARCCA)
The Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 (PPARCCA), spearheaded by the National Psoriasis Foundation and its advocates, was introduced in Congress May 26, 2011…

Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis
OBJECTIVE: To conduct a meta-analysis to assess the effects of available biological agents on the severity of psoriasis, as well as to provide data on the effects of these agents on HRQoL…

Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
OBJECTIVES: To evaluate and compare the efficacy and safety of biological agents in the treatment of plaque psoriasis…

Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology

Phototherapy, PUVA therapy and narrow-band UVB are recognised forms of first-line therapy for extensive and severe plaque psoriasis. Based on a systematic review of the medical literature, we propose a good practice guideline for the use of narrow-band UVB phototherapy in this indication…

Strategy to manage the treatment of severe Psoriasis: considerations of efficacy, safety, and cost
Abstract Psoriasis is a common, unpredictable, chronic immune-mediated disease characterised by skin lesions and frequently associated with arthritis. Although rarely fatal, psoriasis has a tremendous impact on a patients’ quality of life…